ketoconazole has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 6 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
Excerpt | Relevance | Reference |
---|---|---|
"We prospectively tested the hypothesis that prevention of herpes simplex virus infection with acyclovir might also reduce the incidence of bacterial infections in adult patients with acute leukaemia." | 9.07 | Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden. ( Grimfors, G; Järnmark, M; Lerner, R; Ljungman, P; Lönnqvist, B; Nyström-Rosander, C; Oberg, G; Palmblad, J, 1993) |
"We prospectively tested the hypothesis that prevention of herpes simplex virus infection with acyclovir might also reduce the incidence of bacterial infections in adult patients with acute leukaemia." | 5.07 | Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden. ( Grimfors, G; Järnmark, M; Lerner, R; Ljungman, P; Lönnqvist, B; Nyström-Rosander, C; Oberg, G; Palmblad, J, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lönnqvist, B | 2 |
Palmblad, J | 2 |
Ljungman, P | 2 |
Grimfors, G | 2 |
Järnmark, M | 2 |
Lerner, R | 2 |
Nyström-Rosander, C | 2 |
Oberg, G | 2 |
Moore, L | 1 |
Ellis, DH | 1 |
Suppiah, R | 1 |
Byard, RW | 1 |
Toogood, IR | 1 |
Trigg, ME | 1 |
Menezes, AH | 1 |
Giller, R | 1 |
Lanza, L | 1 |
Smith, RJ | 1 |
Sato, Y | 1 |
Peters, C | 1 |
Altman, A | 1 |
Vreugdenhil, G | 1 |
Raemaekers, JM | 1 |
van Dijke, BJ | 1 |
de Pauw, BE | 1 |
Walsh, M | 1 |
White, L | 1 |
Atkinson, K | 1 |
Enno, A | 1 |
Carlsson, B | 1 |
Petrini, B | 1 |
3 trials available for ketoconazole and Precursor Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden.
Topics: Acyclovir; Administration, Oral; Adolescent; Adult; Aged; Bacteremia; Bacterial Infections; Double-B | 1993 |
Itraconazole and multidrug resistance: possible effects on remission rate and disease-free survival in acute leukemia.
Topics: Adolescent; Adult; Drug Resistance; Female; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, A | 1993 |
Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemias.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Candidiasis; Humans; Incidence; Ketocona | 1992 |
3 other studies available for ketoconazole and Precursor Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Complete eradication of Aspergillus fumigatus from the lung in an immunocompromised patient by oral itraconazole.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; | 1993 |
Combined anti-fungal therapy and surgical resection as treatment of disseminated aspergillosis of the lung and brain following BMT.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Child; Female; Humans | 1993 |
Fungal Pseudoallescheria boydii lung infiltrates unresponsive to amphotericin B in leukaemic patients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Humans; Itraconazo | 1992 |